HCPLive Network
Latest Specialty Pharmacy Headlines
Thursday, January 29, 2015
By Davy James, Associate Editor
Breakthrough therapy becomes first treatment approved for cancer that attacks immune system.
Thursday, January 29, 2015
By Davy James, Associate Editor
Use of a hormonal contraceptive for at least 5 years linked to potential increase in development of glioma of the brain.
Thursday, January 29, 2015
By Davy James, Associate Editor
Repurposing drugs that block sodium channels may offer a novel therapy for cancer.
Wednesday, January 28, 2015
By Davy James, Associate Editor
System would provide more treatment options for patients along with evidence of drug safety and efficacy for regulators.
Wednesday, January 28, 2015
By Davy James, Associate Editor
Kidneys transplanted from infant who died days after birth.
Tuesday, January 27, 2015
By Davy James, Associate Editor
Benefits of tamoxifen varies among patients.
Tuesday, January 27, 2015
By Davy James, Associate Editor
Researchers gain insight into the cause of fatigue in MS patients.
Monday, January 26, 2015
By Davy James, Associate Editor
Researchers discover how cancer resists BRAF+MEK inhibitors.
Monday, January 26, 2015
By Davy James, Associate Editor
Nine state region found to have lowest survival rates nationwide.
Sunday, January 25, 2015
By Davy James, Associate Editor
Eribulin evaluated for the first time as an early metastatic breast cancer treatment.
Physician's Money Digest
Medical patients sometimes hear what we say skeptically, but Americans in general will believe any darn thing.
Some brokerages receive "order flow payments" in exchange for routing trades to certain exchanges. This practice is a major money-maker for brokers, but some worry it comes at the expense of clients.